# A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

> **NCT06213038** · PHASE1 · RECRUITING · sponsor: **Youxin Chen** · enrollment: 12 (estimated)

## Conditions studied

- Neovascular Age-related Macular Degeneration

## Interventions

- **GENETIC:** SKG0106

## Key facts

- **NCT ID:** NCT06213038
- **Lead sponsor:** Youxin Chen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-05
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06213038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06213038, "A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06213038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*